The C20/20 Innovation Hub at McMaster University accelerates the development and commercialization of biomaterials and drug delivery systems, with a focus on ocular disorders. Our expert team offers tailored support across early-stage R&D, from synthesis to preclinical validation. With state-of-the-art equipment and flexible project models, we collaborate with companies of all sizes to move innovative therapies from bench to bedside.